XPRO (Expro Group Holdings N.V.) Stock Analysis - Politician Trades

Expro Group Holdings N.V. (XPRO) is a publicly traded Energy sector company. As of May 21, 2026, XPRO trades at $16.97 with a market cap of $1.87B and a P/E ratio of 37.92. XPRO moved +3.33% today. Year to date, XPRO is +18.59%; over the trailing twelve months it is +106.70%. Its 52-week range spans $6.70 to $18.73. Analyst consensus is neutral with an average price target of $19.50. Rallies surfaces XPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded XPRO stock?

Rallies tracks politician and congressional stock disclosures for XPRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

XPRO Key Metrics

Key financial metrics for XPRO
MetricValue
Price$16.97
Market Cap$1.87B
P/E Ratio37.92
EPS$0.45
Dividend Yield0.07%
52-Week High$18.73
52-Week Low$6.70
Volume0
Avg Volume0
Revenue (TTM)$1.61B
Net Income$51.69M
Gross Margin0.00%

Latest XPRO News

Recent XPRO Insider Trades

  • Whelley Eileen Goss sold 2.71K (~$22.17K) on Jun 3, 2025.
  • TROE LISA L sold 2.71K (~$22.17K) on Jun 3, 2025.
  • Jardon Michael bought 45.20K (~$493.13K) on Dec 17, 2024.

XPRO Analyst Consensus

2 analysts cover XPRO: 0 strong buy, 1 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $19.50.

Common questions about XPRO

Which politicians traded XPRO stock?
Rallies tracks politician and congressional stock disclosures for XPRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in XPRO?
Yes. Rallies tracks politician and congressional stock disclosures for XPRO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is XPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XPRO. It does not provide personalized investment advice.
XPRO

XPRO